Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.24−0.16 (-6.67%)
Close on Nov 16, 2026Market cap $5.06MP/E –Yield –
Biodexa Pharmaceuticals EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -0.00 GBP. The highest annual figure on record is -0.00 GBP in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -0.00 GBP | – |
| FY2024 | Dec 31, 2024 | -0.00 GBP | – |
| FY2023 | Dec 31, 2023 | -0.02 GBP | – |
| FY2022 | Dec 31, 2022 | -1.55 GBP | – |
| FY2017 | Dec 31, 2017 | -12400.00 GBP | – |
| FY2016 | Dec 31, 2016 | -22400.00 GBP | – |
| FY2015 | Dec 31, 2015 | -14400.00 GBP | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?